vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $31.1M, roughly 2.0× LIFECORE BIOMEDICAL, INC. \DE\). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
LFCR vs OUST — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $62.2M |
| Net Profit | $-10.0M | — |
| Gross Margin | 25.0% | 60.2% |
| Operating Margin | -9.9% | 1.5% |
| Net Margin | -32.1% | — |
| Revenue YoY | -4.5% | 106.6% |
| Net Profit YoY | -52.0% | — |
| EPS (diluted) | $-0.29 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.2M | ||
| Q3 25 | $31.1M | $39.5M | ||
| Q2 25 | — | $35.0M | ||
| Q1 25 | $35.2M | $32.6M | ||
| Q4 24 | $32.6M | $30.1M | ||
| Q3 24 | $24.7M | $28.1M | ||
| Q2 24 | — | $27.0M | ||
| Q1 24 | $35.7M | $25.9M |
| Q4 25 | — | — | ||
| Q3 25 | $-10.0M | $-21.7M | ||
| Q2 25 | — | $-20.6M | ||
| Q1 25 | $-14.8M | $-22.0M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-16.2M | $-25.6M | ||
| Q2 24 | — | $-23.9M | ||
| Q1 24 | $15.6M | $-23.8M |
| Q4 25 | — | 60.2% | ||
| Q3 25 | 25.0% | 42.1% | ||
| Q2 25 | — | 45.2% | ||
| Q1 25 | 28.0% | 41.3% | ||
| Q4 24 | 34.0% | 43.8% | ||
| Q3 24 | 21.8% | 38.3% | ||
| Q2 24 | — | 33.7% | ||
| Q1 24 | 33.3% | 28.6% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | -9.9% | -61.4% | ||
| Q2 25 | — | -76.5% | ||
| Q1 25 | -25.7% | -73.0% | ||
| Q4 24 | -6.0% | -85.1% | ||
| Q3 24 | -46.9% | -98.0% | ||
| Q2 24 | — | -93.6% | ||
| Q1 24 | -2.5% | -99.5% |
| Q4 25 | — | — | ||
| Q3 25 | -32.1% | -55.0% | ||
| Q2 25 | — | -58.8% | ||
| Q1 25 | -42.0% | -67.5% | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -65.7% | -91.1% | ||
| Q2 24 | — | -88.4% | ||
| Q1 24 | 43.8% | -91.9% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | $-0.29 | $-0.37 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | $-0.47 | $-0.42 | ||
| Q4 24 | $-0.25 | $-0.46 | ||
| Q3 24 | $-0.53 | $-0.54 | ||
| Q2 24 | — | $-0.53 | ||
| Q1 24 | $0.42 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $208.6M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $261.7M |
| Total Assets | $235.2M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $208.6M | ||
| Q3 25 | $18.9M | $244.5M | ||
| Q2 25 | — | $226.5M | ||
| Q1 25 | $5.4M | $168.2M | ||
| Q4 24 | $9.5M | $172.0M | ||
| Q3 24 | — | $151.4M | ||
| Q2 24 | — | $184.2M | ||
| Q1 24 | — | $187.8M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $261.7M | ||
| Q3 25 | $-10.5M | $247.4M | ||
| Q2 25 | — | $221.0M | ||
| Q1 25 | $2.2M | $167.9M | ||
| Q4 24 | $15.4M | $180.9M | ||
| Q3 24 | $-3.9M | $171.7M | ||
| Q2 24 | — | $170.6M | ||
| Q1 24 | $17.7M | $167.2M |
| Q4 25 | — | $349.5M | ||
| Q3 25 | $235.2M | $353.8M | ||
| Q2 25 | — | $321.8M | ||
| Q1 25 | $237.7M | $268.6M | ||
| Q4 24 | $255.4M | $276.1M | ||
| Q3 24 | $246.8M | $255.2M | ||
| Q2 24 | — | $309.9M | ||
| Q1 24 | $246.2M | $317.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-15.4M |
| Free Cash FlowOCF − Capex | $25.0K | $-37.2M |
| FCF MarginFCF / Revenue | 0.1% | -59.8% |
| Capex IntensityCapex / Revenue | 5.6% | 35.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-15.4M | ||
| Q3 25 | $1.8M | $-18.3M | ||
| Q2 25 | — | $-1.3M | ||
| Q1 25 | $1.2M | $-4.9M | ||
| Q4 24 | $-6.1M | $-2.6M | ||
| Q3 24 | $-613.0K | $-3.8M | ||
| Q2 24 | — | $-21.6M | ||
| Q1 24 | $-1.4M | $-5.7M |
| Q4 25 | — | $-37.2M | ||
| Q3 25 | $25.0K | $-20.0M | ||
| Q2 25 | — | $-2.2M | ||
| Q1 25 | $-4.3M | $-5.4M | ||
| Q4 24 | $-8.6M | $-4.0M | ||
| Q3 24 | $-4.0M | $-4.3M | ||
| Q2 24 | — | $-22.0M | ||
| Q1 24 | $-7.8M | $-7.1M |
| Q4 25 | — | -59.8% | ||
| Q3 25 | 0.1% | -50.7% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | -12.1% | -16.6% | ||
| Q4 24 | -26.3% | -13.3% | ||
| Q3 24 | -16.3% | -15.4% | ||
| Q2 24 | — | -81.5% | ||
| Q1 24 | -21.8% | -27.4% |
| Q4 25 | — | 35.0% | ||
| Q3 25 | 5.6% | 4.3% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | 15.5% | 1.7% | ||
| Q4 24 | 7.5% | 4.8% | ||
| Q3 24 | 13.9% | 2.0% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 17.8% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
OUST
Segment breakdown not available.
